HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 856464Generated: October 28, 2026
m-Chloroperbenzoic acid → HCID 69522517, compound
https://huagongshe.com/reaction/856464
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | m-Chloroperbenzoic acid | HCID 70297 | — |
| Reactant | HCID 69521219 | HCID 69521219 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 69522517 | HCID 69522517 | 40% |
Reaction Steps
To a solution of 7-[4-(2-butoxyethoxy)phenyl]-1-isobutyl-N-[4-[[1-methylimidazol-2-yl]sulfanyl]phenyl]-2,3-dihydro-1-benzazepine-4-carboxamide (600 mg) in dichloromethane (15 ml) was added dropwise 70% solution of 3-chloroperbenzoic acid (355 mg) in dichloromethane (15 ml) at −78° C. The reaction vessel was removed from a dry ice-acetone bath, and sodium thiosulfate solution was added to the reaction vessel with strongly stirring. The mixture was allowed to be at room temperature, stirred for 30 minutes, and extracted with ethyl acetate. The organic layer was washed with an aqueous solution of saturated sodium bicarbonate and saturated brine, dried over magnesium sulfate. The solvent was distilled off under reduced pressure and the obtained residue was separated and purified by silica gel column chromatography (ethyl acetate), to give 7-[4-(2-butoxyethoxy)phenyl]-1-isobutyl-N-[4-[[1-methylimidazol-2-yl]sulfinyl]phenyl]-2,3-dihydro-1-benzazepine-4-carboxamide (246 mg) (Compound 160) as yellow amorphous.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07262185B2 |
|---|
| Source dataset | uspto-grants-2007_08 |
|---|
| ORD ID | ord-8a4e47d1bc674cf5b9d118e8935d62aa |
|---|
| Source note | uspto-grants-2007_08 |
|---|